BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30606698)

  • 1. Comparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver disease.
    Stasi C; Tsochatzis EA; Hall A; Rosenberg W; Milani S; Dhillon AP; Pinzani M
    Dig Liver Dis; 2019 Jul; 51(7):1001-1007. PubMed ID: 30606698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis.
    Isgro G; Calvaruso V; Andreana L; Luong TV; Garcovich M; Manousou P; Alibrandi A; Maimone S; Marelli L; Davies N; Patch D; Dhillon AP; Burroughs AK
    J Gastroenterol; 2013 Aug; 48(8):921-9. PubMed ID: 23124603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation.
    Manousou P; Burroughs AK; Tsochatzis E; Isgro G; Hall A; Green A; Calvaruso V; Ma GL; Gale J; Burgess G; O'Beirne J; Patch D; Thorburn D; Leandro G; Dhillon AP
    J Hepatol; 2013 May; 58(5):962-8. PubMed ID: 23262247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen proportionate area of liver tissue determined by digital image analysis in patients with HBV-related decompensated cirrhosis.
    Xie SB; Ma C; Lin CS; Zhang Y; Zhu JY; Ke WM
    Hepatobiliary Pancreat Dis Int; 2011 Oct; 10(5):497-501. PubMed ID: 21947723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation.
    Calvaruso V; Dhillon AP; Tsochatzis E; Manousou P; Grillo F; Germani G; Patch D; O'Beirne J; Burroughs AK
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1227-32. PubMed ID: 22432427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equilibrium contrast-enhanced CT imaging to evaluate hepatic fibrosis: initial validation by comparison with histopathologic sampling.
    Bandula S; Punwani S; Rosenberg WM; Jalan R; Hall AR; Dhillon A; Moon JC; Taylor SA
    Radiology; 2015 Apr; 275(1):136-43. PubMed ID: 25490188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation.
    Manousou P; Dhillon AP; Isgro G; Calvaruso V; Luong TV; Tsochatzis E; Xirouchakis E; Kalambokis G; Cross TJ; Rolando N; O'Beirne J; Patch D; Thornburn D; Burroughs AK
    Liver Transpl; 2011 Feb; 17(2):178-88. PubMed ID: 21280191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis.
    Calvaruso V; Di Marco V; Bavetta MG; Cabibi D; Conte E; Bronte F; Simone F; Burroughs AK; Craxì A
    Aliment Pharmacol Ther; 2015 Mar; 41(5):477-86. PubMed ID: 25580867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-Head Comparison between Collagen Proportionate Area and Acoustic Radiation Force Impulse Elastography in Liver Fibrosis Quantification in Chronic Hepatitis C.
    Chen SH; Peng CY; Lai HC; Chang IP; Lee CJ; Su WP; Lin CH; Kao JT; Chuang PH
    PLoS One; 2015; 10(10):e0140554. PubMed ID: 26461105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity.
    Fagan KJ; Pretorius CJ; Horsfall LU; Irvine KM; Wilgen U; Choi K; Fletcher LM; Tate J; Melino M; Nusrat S; Miller GC; Clouston AD; Ballard E; O'Rourke P; Lampe G; Ungerer JP; Powell EE
    Liver Int; 2015 Jun; 35(6):1673-81. PubMed ID: 25495373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appraising diagnostic performance of ELF test by pathological staging and digital quantification of liver fibrosis.
    Gunes Yegin E; Durusoy SS; Ture Ozdemir F; Kombak EF; Ataizi-Celikel C; Ozdogan OC
    Ann Hepatol; 2019; 18(6):833-840. PubMed ID: 31558418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
    J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
    Fernandes FF; Ferraz ML; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Figueiredo F; Perez RM
    J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C.
    Parkes J; Guha IN; Roderick P; Harris S; Cross R; Manos MM; Irving W; Zaitoun A; Wheatley M; Ryder S; Rosenberg W
    J Viral Hepat; 2011 Jan; 18(1):23-31. PubMed ID: 20196799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient.
    Calvaruso V; Burroughs AK; Standish R; Manousou P; Grillo F; Leandro G; Maimone S; Pleguezuelo M; Xirouchakis I; Guerrini GP; Patch D; Yu D; O'Beirne J; Dhillon AP
    Hepatology; 2009 Apr; 49(4):1236-44. PubMed ID: 19133646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C.
    Guéchot J; Trocmé C; Renversez JC; Sturm N; Zarski JP;
    Clin Chem Lab Med; 2012 Jan; 50(4):693-9. PubMed ID: 22505560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease.
    Irvine KM; Wockner LF; Shanker M; Fagan KJ; Horsfall LU; Fletcher LM; Ungerer JP; Pretorius CJ; Miller GC; Clouston AD; Lampe G; Powell EE
    Liver Int; 2016 Mar; 36(3):370-7. PubMed ID: 26104018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive fibrosis score for hepatitis delta.
    Lutterkort GL; Wranke A; Yurdaydin C; Budde E; Westphal M; Lichtinghagen R; Stift J; Bremer B; Hardtke S; Keskin O; Idilman R; Koch A; Manns MP; Dienes HP; Wedemeyer H; Heidrich B
    Liver Int; 2017 Feb; 37(2):196-204. PubMed ID: 27428078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study.
    Afdhal NH; Bacon BR; Patel K; Lawitz EJ; Gordon SC; Nelson DR; Challies TL; Nasser I; Garg J; Wei LJ; McHutchison JG
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):772-9.e1-3. PubMed ID: 25528010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease.
    Buzzetti E; Hall A; Ekstedt M; Manuguerra R; Guerrero Misas M; Covelli C; Leandro G; Luong T; Kechagias S; Manesis EK; Pinzani M; Dhillon AP; Tsochatzis EA
    Aliment Pharmacol Ther; 2019 May; 49(9):1214-1222. PubMed ID: 30882933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.